Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Neonc Technologies, Inc.
Debiopharm International SA
National Institutes of Health Clinical Center (CC)
University of Miami
Alaunos Therapeutics
BioMimetix JV, LLC
Northwell Health
Northwell Health